Overview

CJC-1295 + Ipamorelin is a two-component lyophilized research formulation of modified GRF (1–29) and ipamorelin in a single vial.

Molecular Identity

  • CAS number: 170851-70-4 (ipamorelin); 863288-34-0 (modified GRF (1–29))
  • Mod GRF (1-29): C152H252N44O42, 3367.9 g/mol; 29 amino acids; sequence Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
  • Ipamorelin: C38H49N9O5, 711.9 g/mol; 5 amino acids; sequence Aib-His-D-2Nal-D-Phe-Lys-NH2
  • Supplied form: Lyophilized powder
  • Catalog contents: 10 mg per vial: 5 mg modified GRF (1–29) + 5 mg ipamorelin

Laboratory Research Context

In laboratory settings, CJC-1295 + Ipamorelin Blend is used as a reference material in analytical, biochemical and in-vitro work, including:

  • GHRH receptor and GHS-R1a co-activation
  • Pituitary cell models
  • Combined versus single-agent comparisons

Analytical Quality

Each batch is tested by HPLC (≥99% purity) with identity confirmed by mass spectrometry. Batch results are recorded on the Certificate of Analysis, available from our Lab Test Results page.

Catalog Listing

View CJC-1295 + Ipamorelin Blend in the catalog

Educational Disclaimer

This page describes molecular identity and in-vitro laboratory research context only. It makes no claims about effects in humans or animals and is not medical advice. All products are sold for laboratory research use only and are not for human or veterinary use, or for diagnostic or therapeutic use.